【英文論文】

Nakashima H, Oniki K, Nishimura M, Ogusu N, Shimomasuda M, Ono T, Matsuda K, Yasui-Furukori N, Nakagawa K, Ishitsu T, Saruwatari J.
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
PLoS One. 2015;10(10):e0141266.

Kajiwara A, Kita A, Saruwatari J, Oniki K, Morita K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.
Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus.
Clin Drug Investig. 2015;35(9):593-600.

Oniki K, Saruwatari J, Izuka T, Kajiwara A, Morita K, Sakata M, Otake K, Ogata Y, Nakagawa K.
Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
PLoS One. 2015 ;10(7):e0132640.

Morita K, Masuda N, Tanaka T, Saruwatari J, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
A functional variant in the γ-glutamyl transferase (GGT) 1 gene is associated with airflow obstruction in smokers.
Clin Chem Lab Med. 2015 ;53(12):e339-341.

Morita K, Masuda N, Oniki K, Saruwatari J, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
Association between the aldehyde dehydrogenase 2*2 allele and smoking-related chronic airway obstruction in a Japanese general population: A pilot study.
Toxicol Lett. 2015;236(2):117-122.

Tsuchimine S, Saruwatari J, Kaneda A, Yasui-Furukori N.
ABO Blood Type and Personality Traits in Healthy Japanese Subjects.
PLoS One. 2015 ;10(5):e0126983.

Jinnouchi H, Morita K, Takahiro T, Kajiwara A, Kawata Y, Oniki K, Saruwatari J, Nakagawa K, Otake K, Ogata Y, Yoshida A, Hokimoto S, Ogawa H.
Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.
Cardiovasc Diabetol. 2015;14(1):49.

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K.
Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy.
Neuropsychiatr Dis Treat. 2015;11:1007-1014.

Hokimoto S, Akasaka T, Tabata T, Arima Y, Tsujita K, Sakamoto K, Kaikita K, Morita K, Kumagae N, Yamamoto E, Oniki K, Nakagawa K, Ogawa H.
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.
Thromb Res. 2015;135(6):1081-1086.

Marume K, Hokimoto S, Tabata N, Akasaka T, Tsujita K, Sakamoto K, Yamamoto E, Yamamuro M, Kaikita K, Oniki K, Nakagawa K, Ogawa H.
Intraprocedural thrombotic event during coronary intervention depends on CYP2C19 genotype and is a predictor of future clinical event.
Int J Cardiol. 2015;187:231-233.

Sueta D, Hokimoto S, Enomoto K, Ono T, Tabata T, Kajiwara I, Kaikita K, Saruwatari J, Oniki K, Nakagawa K, Ogawa H.
A case of repetitive and simultaneous stent thrombosis.
Int J Cardiol. 2015;186:210-212.

Nakagawa K, Kajiwara A.
Female sex as a risk factor for adverse drug reactions.
Nippon rinsho. Japanese journal of clinical medicine. 2015;73(4):581-5.

Hokimoto S, Tabata N, Akasaka T, Arima Y, Kaikita K, Morita K, Kumagae N, Oniki K, Nakagawa K, Ogawa H.
Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease.
J Cardiovasc Pharmacol. 2015;65(2):148-152.

Arima Y, Hokimoto S, Akasaka T, Mizobe K, Oniki K, Nakagawa K, Ogawa H.
Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina.
J Cardiol. 2015;65(6):494-500.

Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.
Associations between the common HNF1A gene variant p.I27L (rs1169288) and risk of type 2 diabetes mellitus are influenced by weight.
Diabetes Metab. 2015;41(1):91-94.

【和文総説】

中川和子，梶原彩文
性差による薬物の副作用発現．
日本臨牀 73, 581-585, 2015.

田口和明、猿渡淳二、平田憲史郎、丸山徹．
TDMの落とし穴〜偽陽性と偽陰性〜．
医療薬学 41, 215-222, 2015